Laboratory Safety of Long-Term Dupilumab Treatment in a 5-Year Open-Label Extension Study of Adults with Moderate-To-Severe Atopic Dermatitis

This poster is currently being presented at Atlantic Derm Conference on December 4, 2024. You’ll be able to see this poster after the conference is finished.